首页> 美国卫生研究院文献>Chronic Diseases and Translational Medicine >Challenge in the new era: Translational medicine in gastrointestinal endoscopy and early cancer
【2h】

Challenge in the new era: Translational medicine in gastrointestinal endoscopy and early cancer

机译:新时代的挑战:胃肠道内窥镜和早期癌症中的转化医学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Translational medicine is a new medical model that has emerged over the past 20 years and is dedicated to bridging the gap between basic and clinical research. At the same time, the diagnosis and treatment of digestive diseases, especially gastrointestinal endoscopy, have been rapidly developed. The emergence of new techniques for gastrointestinal endoscopy has changed the therapeutic spectrum of some diseases and brought huge benefits to patients. Targeted therapy has positively affected the individualized and precise treatment of patients with advanced gastrointestinal cancer. The construction of a standardized biobank provides a strong guarantee for clinicians to conduct translational medical research. Translational medicine has brought good development opportunities, but it also faces challenges. The training of translational medicine researchers and the transformation of educational models require sufficient attention for further development.
机译:转化医学是过去20年来出现的一种新的医学模型,致力于缩小基础研究与临床研究之间的差距。同时,消化系统疾病的诊断和治疗,尤其是胃肠道内窥镜检查已得到迅速发展。胃肠内窥镜检查新技术的出现改变了某些疾病的治疗范围,并给患者带来了巨大的利益。靶向治疗已积极影响晚期胃肠道癌患者的个性化和精确治疗。标准化生物库的建设为临床医生进行转化医学研究提供了有力的保证。转化医学带来了良好的发展机遇,但同时也面临挑战。转化医学研究人员的培训和教育模式的转变需要得到进一步发展的足够重视。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号